Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts

Oncogene

Volumn 17, Issue 6, 1998, Pages 709-717

  Gollahon, Lauren S ^a,c   Kraus, Eliyahu ^b   Wu, Tian Ai ^b   Yim, Sun O ^b   Strong, Louise C ^b   Shay, Jerry W ^a   Tainsky, Michael A ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c TEXAS TECH UNIVERSITY   (United States)

Author keywords

ALT pathway; Cell hybrids; p53; Senescence; Telomeres

Indexed keywords

TELOMERASE;

ARTICLE; CARCINOGENICITY; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME ACTIVITY; FAMILIAL CANCER; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; ONCOGENE RAS; PRIORITY JOURNAL; SKIN FIBROBLAST; TELOMERE;

MUS MUSCULUS;

EID: 0032514373     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201987     Document Type: Article

References (75)

1. Agarwal ML, Agarwal A, Taylor WR and Stark GR. (1995). Proc. Natl. Acad. Sci. USA, 92, 8493-8497.
2. Avery OT, MacLeod CM and McCarty M. (1944). J. Exp. Med., 79, 137-158.
3. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S and Greider CW. (1996). Cancer Res., 56, 645-650.
4. Bacchetti S and Counter C. (1995). Int. J. Oncol., 7, 423-432.
5. Band V, Dalal S, Delmolino L and Androph YEJ. (1993). EMBO J., 12, 1847-1852.
6. Barrett JC. (1993). Molecular Genetics of Nervous System Tumors, Levine AJ and Schmidek HH (eds). Wiley-Liss: New York, pp 61-72.
7. Bischoff F, Strong L, Yim S, Pathak S, Pratt D, Grant G, Sicillano M, Giovanella B and Tainsky M. (1991). Oncogene, 6, 183-186.
8. Bischoff FZ, Yim SO, Pathak S, Grant GMJ, S, Giovanella BC, Strong LC and Tainsky MA. (1990). Cancer Res., 50, 7979-7984.
9. Blackburn EH. (1991). Nature, 350, 569-573.
10. Blackburn EH. (1994). Cell, 77, 621-623.
11. Blasco M, Lee H-W, Hande M, Samper E, Lansdorp P, DePinho R and Grieder C. (1997). Cell, 91, 25-34.
12. Bryan TM, Engelzou A, Gupta J, Bachetti S and Reddel RR. (1995). EMBO J., 14, 4240-4248.
13. Buchkovich K and Greider CW. (1996). Mol. Biol. Cell, 7, 1443-1454.
14. Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P and de Lange T. (1995). Science, 270, 1663-1667.
15. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S. (1992). EMBO J., 11, 1921-1929.
16. Duncan EJ, Whitaker NJ, Moy EL and Reddel RR. (1993). Exp. Cell Res., 205, 337-344.
17. Eliyahu D, Raz A, Gruss P, Givol D and Oren M. (1984a). Nature, 312, 646-649.
18. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B. (1995). Science, 269, 1236-1239.
19. Gao Q, Hauser SH, Liu XL, Wazer DE, Madoc-Jones H and Band V. (1996). Cancer Res., 56, 3129-3133.
20. Gillespie PG and Hudspeth AJ. (1991). Proc. Natl. Acad. Sci. USA, 88, 2563-2567.
21. Gollahon LS and Shay JW. (1996). Oncogene, 12, 715-725.
22. Gossen M and Bujard H. (1992). Proc. Natl. Acad. Sci. USA, 89, 5547-5551.
23. Graham FL and Smiley J. (1977). J. Gen. Virol., 36, 59-74.
24. Greider CW. (1991). Curr. Opin. Cell Biol., 3, 444-451.
25. Gutman A and Wasylyk B. (1991). Trends Genetics, 7, 49-54.
26. Harley CB. (1991). Mutat. Res., 256, 271-282.
27. Harley CB, Fletcher AB and Greider CW. (1990). Nature, 345, 458-460.
28. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, Piatyszek MA, Wright WE and Shay JW. (1994). Cold Spring Harbor Symposia on Quantitative Biology, pp 307-315.
29. Harley CB and Villaponteau B. (1995). Curr. Opin. Genetics Develop., 5, 249-255.
30. Holt SE, Aisner DL, Shay JW and Wright WE. (1997). Proc. Natl. Acad. Sci. USA, 94, 10687-10692.
31. Holt SE, Norton JC, Wright WE and Shay JW. (1996a). Methods Cell Science, 18, 237-248.
32. Holt SE, Wright WE and Shay JW. (1996b). Mol. Cell. Biol., 16, 2932-2939.
33. Hsiao R, Sharma HW, Ramakrishnan S, Keith E and Narayanan R. (1997). Anticancer Res., 17, 827-832.
34. Huschtscha LL and Holliday R. (1983). J. Cell Sci., 63, 77-99.
35. Jordan C. (1990). In Situ Hybridization Histochem., Chesselet M-F (ed) CRC Press: Boston, pp 61-63.
36. Karlsson C, Stenman G, Vojta PJ, Bongcam-Rudloff E, Barrett JC, Westermark B and Paulsson Y. (1996). Cancer Res., 56, 241-245.
37. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW. (1994). Science, 266, 2011-2015.
38. Lansdorp PM, Verwood NP, Van de Rijke FM, Dragowska V, Little M-T, Dirks RW, Raap AK and Tanke HJ. (1996). Hum. Mol. Genet., 5, 685-691.
39. Lemoine NR, Staddon S, Bond J, Wyllie FS, Shaw JJ and Wynford-Thomas D. (1990). Oncogene, 5, 1833-1837.
40. Mayne LV, Priestley A, James MR and Burkes JR. (1986). Exp. Cell Res., 162, 530-538.
41. Mayne LV, Priestley A, James MR and Burke JR. (1986). Exp. Cell Res., 162, 530-538.
42. McCormick JJ and Maher VM. (1988). Mutat. Res., 199, 273-291.
43. Murnane JP, Sabatier L, Marder BA and Morgan WF. (1994). EMBO J., 13, 4953-4962.
44. Ohmura H, Tahara H, Suzuki M, Ide T, Shimizu M, Yoshida MA, Tahara E, Shay JW, Barrett JC and Oshimura M. (1995). Jap. J. Cancer Res., 86, 899-904.
45. Olovnikov AM. (1973). J. Theoretical Biol., 41, 181-190.
46. Pereira-Smith OM. and Smith JR. (1988). Proc. Natl. Acad. Sci. USA, 85, 6042-6046.
47. Piatyszek MA, Kim NW, Weinrich SL, Keiko H, Hiyama E, Wright WE and Shay JW. (1996). Methods Cell Sci., 17, 1-15.
48. Rainey WH, Sawetawan C, Shay JW, Michael MD, Mathis JM, Kutteh W, Byrd W and Carr BR. (1994). J. Clin. Endocrinol. Metab., 78, 705-710.
49. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, Moy EL, Englezou A, Warneford SG, Dalla-Pozza L and Reddel RR. (1995). Mol. Cell. Biol., 15, 4745-4753.
50. Ross SR, Linzer DI, Flint SJ and Levine AJ. (1978). Persistent viruses, Vol. II. Stevens JG et al. (eds). Academic Press: New York, pp 469-484.
51. Sarnow P, Ho YS, Williams J and Levine AJ. (1982). Cell, 28, 387-394.
52. Sasaki M, Honda T, Yamada H, Wake N, Barrett JC and Oshimurs M. (1994). Cancer Res., 54, 6090-6093.
53. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. (1990). Cell, 63, 1129-1136.
54. Shay JW and Bacchetti S. (1997). Euro. J. Cancer, 5, 787-791.
55. Shay JW, Brasiskyte D, Ouellette M, Piatyszek MA, Werbin H, Ying Y and Wright WE. (1994). Meth. Mol. Genet., 5, 263-280.
56. Shay JW, Pereira-Smith OM and Wright WE. (1991a). Exp. Cell Res., 196, 33-39.
57. Shay JW, Tomlinson G, Piatyszek MA and Gollahon LS. (1995). Mol. Cell. Biol., 15, 425-432.
58. Shay JW, Van Der Haegen BA, Ying Y and Wright WE. (1993a). Exp. Cell Res., 209, 45-52.
59. Shay JW and Wright WE. (1996). Curr. Opin. Oncol., 8, 66-71.
60. Shay JW, Wright WE, Brasiskyte D and Van Der Haegen BA. (1993b). Oncogene, 8, 1407-1413.
61. Shay JW, Wright WE and Werbin H. (1991b). Biochim. Biophys. Acta, 1072, 1-7.
62. Slingerland JM, Jenkins JR and Benchimol S. (1993). EMBO J., 12, 1029-1037.
63. Tainsky M, Bischoff F and Strong L. (1995). Can. Metast. Rev., 14, 43-48.
64. Tsutsui T, Fujino T, Kodama S, Tainsky MA, Boyd J and Barrett JC. (1995). Carcinogenesis, 16, 25-34.
65. Tsutsui T, Tanaka Y, Matsudo Y, Hasegawa K, Fujino T, Kodama S and Barrett J. (1997). Mol. Carcin., 18, 7-18.
66. Van Der Haegen BA and Shay JW. (1993). In Vitro Cell. Devel. Biol., 29A, 180-182.
67. Watanabe S, Kanda T and Yoshiike K. (1993). Jpn. J. Cancer Res., 84, 1043-1049.
68. Watson JD. (1972). Nature, 239, 197-201.
69. Wazer DE, Liu XL, Chu Q, Gao Q and Band V. (1995). Proc. Natl. Acad. Sci. USA, 92, 3687-3691.
70. Werness BA, Levine AJ and Howley PM. (1990). Science, 248, 76-79.
71. Wright WE, Brasiskyte D, Piatyszek MA and Shay JW. (1996). EMBO J., 15, 1734-1741.
72. Wright WE, Pereira-Smith OM and Shay JW. (1989). Mol. Cell. Biol., 9, 3088-3092.
73. Wright WE and Shay JW. (1992). Exp. Gerontol., 27, 383-389.
74. Wyllie FS, Lemoine NR, Barton CM, Dawson T, Bond J and Wynford-Thomas D. (1993). Mol. Carcinog., 7, 83-88.
75. Yashima K, Milchrug S, Gollahon LS, Maitra A, Saboorian MH, Shay JW and Gazdar AF. (1991). Clinical Cancer Res., 4, 229-234.